(Q37972994)

26 August 2017

title

Successful treatment of adult-onset Still's disease with tocilizumab monotherapy: two case reports and literature review (English)

1 reference

adult-onset Still's disease

26 August 2017

1 reference

1 reference

Ryota Sakai

1

1 reference

26 August 2017

Hayato Nagasawa

2

1 reference

26 August 2017

Eiko Nishi

3

1 reference

26 August 2017

Ayumi Okuyama

4

1 reference

26 August 2017

Hirofumi Takei

5

1 reference

26 August 2017

Takahiko Kurasawa

6

1 reference

26 August 2017

Tsuneo Kondo

7

1 reference

26 August 2017

Koji Nishimura

8

1 reference

26 August 2017

Yuichiro Shirai

9

1 reference

26 August 2017

Tatsuya Ito

10

1 reference

26 August 2017

Hideto Kameda

11

1 reference

26 August 2017

Tsutomu Takeuchi

12

1 reference

26 August 2017

Koichi Amano

13

1 reference

26 August 2017

publication date

4 January 2012

1 reference

26 August 2017

published in

Clinical Rheumatology

1 reference

26 August 2017

volume

31

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

569-574

1 reference

Still's disease in the adult

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1917-9

Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1917-9

Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1917-9

Rapid responses to anakinra in patients with refractory adult-onset Still's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1917-9

A case of refractory adult-onset Still’s disease successfully controlled with tocilizumab and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1917-9

Etanercept-refractory adult-onset Still's disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1917-9

Tocilizumab in refractory adult Still's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1917-9

Tocilizumab in refractory adult-onset Still's disease with aseptic meningitis--efficacy of interleukin-6 blockade and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1917-9

Methotrexate treatment in patients with adult onset Still's disease--retrospective study of 13 Japanese cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1917-9

Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1917-9

Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1917-9

Exacerbation of adult-onset Still's disease, possibly related to elevation of serum tumor necrosis factor-alpha after etanercept administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-011-1917-9

Benefit and a possible risk of tocilizumab therapy for adult-onset Still’s disease accompanied by macrophage-activation syndrome

21 January 2018

1 reference

12 December 2020

Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's disease

1 reference

12 December 2020

Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still's disease

1 reference

12 December 2020

Guidance on using tocilizumab for juvenile idiopathic arthritis.

1 reference

12 December 2020

Low dose methotrexate treatment in adult Still's disease

1 reference

12 December 2020

Tocilizumab for multirefractory adult-onset Still's disease

1 reference

12 December 2020

Treatment of refractory adult-onset Still's disease with tocilizumab: report of two cases and review of the literature

1 reference

12 December 2020

Preliminary criteria for classification of adult Still's disease

1 reference

12 December 2020

Successful tocilizumab treatment in a patient with adult-onset Still's disease complicated by chronic active hepatitis B and amyloid A amyloidosis

1 reference

12 December 2020

Elevated serum interleukin 6, interferon-gamma, and tumor necrosis factor-alpha levels in patients with adult Still's disease

1 reference

12 December 2020

Case report: successful use of short-term add-on tocilizumab for multirefractory systemic flare of adult-onset Still's disease.

1 reference

12 December 2020

Successful treatment of adult-onset Still's disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade

1 reference

12 December 2020

Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease.

1 reference

12 December 2020

Glucocorticoid and cyclosporine refractory adult onset Still's disease successfully treated with tocilizumab

1 reference

12 December 2020

IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease

1 reference

12 December 2020

Successful treatment with tocilizumab in a patient with refractory adult-onset Still's disease (AOSD)

1 reference

12 December 2020

Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences

1 reference

12 December 2020

Adult-onset Still's disease

1 reference

12 December 2020

A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6 years

1 reference

12 December 2020

10.1007/S10067-011-1917-9

Identifiers

DOI

1 reference

release_hnoq6y2ghvgapaefby6xbjwihu

26 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hnoq6y2ghvgapaefby6xbjwihu

24 November 2022

mapped directly with Wikidata item

1 reference